Profound Medical Corp. (NASDAQ: PROF)
$9.68
+0.5300 ( +5.79% ) 178.3K
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.
Market Data
Open
$9.68
Previous close
$9.15
Volume
178.3K
Market cap
$236.96M
Day range
$9.50 - $10.40
52 week range
$7.11 - $13.07
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
6-k | Quarterly Reports | 2 | Jun 14, 2024 |
6-k | Quarterly Reports | 4 | Jun 03, 2024 |
6-k | Quarterly Reports | 2 | May 16, 2024 |
6-k | Quarterly Reports | 2 | May 14, 2024 |
6-k | Quarterly Reports | 7 | May 09, 2024 |
6-k | Quarterly Reports | 2 | May 06, 2024 |
6-k | Quarterly Reports | 2 | Apr 22, 2024 |
6-k | Quarterly Reports | 2 | Apr 09, 2024 |
40-f | Other | 116 | Mar 07, 2024 |
6-k | Quarterly Reports | 2 | Mar 07, 2024 |